Chris Bardon, M.D.
InvestorFounderManaging Partner at MPM BioImpact · Founder at Frontier Medicines
FoundedFrontier Medicines
Find your path to Chris
58 people in our graph share verified history with Chris — schools, employers, funds. One of them is your warm intro.
Christiana BardonunlockedChris: together at MPM BioImpact
×11Chris: together at MPM BioImpact
About
Managing Partner at MPM BioImpact with medical background, involved in early investment identification and portfolio strategy.
Founder at Frontier Medicines
Intro paths
→
In turn, Chris can intro founders to Frontier Medicines's investors below.
Frontier Medicines's investors · 7
Berkeley CatalystBerkeley · since 2021DCVC (Data Collective)Palo Alto · $5M – $25M checks · since 2021DCVC BioPalo Alto · since 2025Deerfield Management CompanyNew York · since 2025Droia VenturesLeuven · $540K checks · since 2021MPM BioImpactBoston · $1M – $15M checks · since 2021RA CapitalBoston · since 2021
Co-founders at Frontier Medicines
CV
Chris VarmaCo-founder, Chairman and CEO
Colleagues at MPM BioImpact
Alan Kelly
Director at MPM BioImpact
Andrew Scharenberg
Entrepreneur Partner at MPM BioImpact
Ansbert Gadicke, M.D.
Chairman at MPM BioImpact
Ansbert K. Gadicke
Managing Partner at MPM BioImpact
Aparna Parikh
Entrepreneur Partner at MPM BioImpact
Bard Geesaman
Managing Partner at MPM Capital
Binsen Li
Principal at MPM BioImpact
Brendan Furey
Chief Compliance Officer at MPM BioImpact
Frequently asked questions
- Who is Chris Bardon, M.D.?
- Managing Partner at MPM BioImpact with medical background, involved in early investment identification and portfolio strategy.
- Where does Chris Bardon, M.D. work?
- Chris Bardon, M.D. is Founder of Frontier Medicines and Managing Partner at MPM BioImpact.
- What companies did Chris Bardon, M.D. found?
- Chris Bardon, M.D. founded Frontier Medicines.